SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

USFDA concludes inspection at Caplin Point Laboratories’ Sterile Injectable Site

07 Sep 2018 Evaluate

United States Food and Drug Administration (USFDA) has conducted an inspection at Caplin Point Laboratories’ Sterile Injectable Site (CP - IV) located at Gummudipoondi in the state of Tamil Nadu, from August 30, 2018 to September 06, 2018. This was a scheduled inspection and at the end of the inspection, there were ZERO 483s.

Caplin Point Laboratories is engaged mainly in manufacturing a wide range of Ointments, Creams and other External application preparations in addition to the regular segments of pharmaceutical formulations.

Caplin Point Labs. Share Price

2558.40 51.15 (2.04%)
29-Jun-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1872.60
Dr. Reddys Labs. 1376.30
Cipla 1453.50
Zydus Lifesciences 1121.65
Lupin 2407.45
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: